Indiana Lysis Technologies

10:45 AM - 11:00 AM, Thursday, June 6, 2019 ・ SuS - Hall E, Booth 3971, Level 200
Nanotechnology startup company developing nanoparticles to digest and dissolve pulmonary embolisms without the risk of hemorrhagic internal bleeding, which is a risk associated with current blood clot treatments. This technology will reduce off-target bleeding and could be expanded for use in treating other types of blood clots that currently cannot be effectively treated due to risk of internal bleeding, thus meeting unmet medical needs of a significant patient population within the United States.
Moderator
photo
President and CEO
Indiana Lysis Technologies
Speaker
photo
President and CEO
Indiana Lysis Technologies